Get the Stockscreener App
71.39
0.21%
-0.15
After Hours:
71.39
Arcellx Inc stock is traded at $71.39, with a volume of 382.32K.
It is down -0.21% in the last 24 hours and up +8.41% over the past month.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
See More
Previous Close:
$71.54
Open:
$71.6
24h Volume:
382.32K
Relative Volume:
0.58
Market Cap:
$3.93B
Revenue:
$76.81M
Net Income/Loss:
$-162.42M
P/E Ratio:
-23.88
EPS:
-2.99
Net Cash Flow:
$-122.49M
1W Performance:
+1.59%
1M Performance:
+8.41%
6M Performance:
+4.78%
1Y Performance:
+15.50%
1-Day Range:
$70.61
$72.69
1-Week Range:
$69.30
$74.43
52-Week Range:
$47.86
$107.37
Arcellx Inc Stock (ACLX) Company Profile
Name
Arcellx Inc
Sector
Industry
Phone
240-327-0603
Address
800 BRIDGE PARKWAY, REDWOOD CITY
Compare ACLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
71.39 | 3.94B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Initiated | Citigroup | Buy |
| Oct-08-24 | Initiated | Redburn Atlantic | Buy |
| Sep-03-24 | Initiated | Cantor Fitzgerald | Overweight |
| May-31-24 | Initiated | Piper Sandler | Overweight |
| Mar-07-24 | Initiated | Morgan Stanley | Overweight |
| Jan-04-24 | Reiterated | Needham | Buy |
| Dec-19-23 | Initiated | Scotiabank | Sector Outperform |
| Oct-30-23 | Initiated | TD Cowen | Outperform |
| Oct-17-23 | Initiated | UBS | Buy |
| May-18-23 | Initiated | Truist | Buy |
| Apr-14-23 | Initiated | Robert W. Baird | Outperform |
| Mar-14-23 | Initiated | Stifel | Buy |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-13-22 | Resumed | BofA Securities | Buy |
| Oct-31-22 | Initiated | Guggenheim | Buy |
| Oct-27-22 | Initiated | Needham | Buy |
| Jul-20-22 | Initiated | Canaccord Genuity | Buy |
| Mar-01-22 | Initiated | BofA Securities | Buy |
| Mar-01-22 | Initiated | SVB Leerink | Outperform |
View All
Arcellx Inc Stock (ACLX) Latest News
What catalysts could drive Arcellx Inc. stock higher in 2025Swing Trade Report To Watch Now - jammulinksnews.com
Arcellx price target raised to $133 from $93 at Scotiabank - TipRanks
Heatmap Data Shows High Activity in Arcellx Inc. SectorTrade Insight With Community Collaboration Supported - metal.it
How Arcellx Inc. stock performs during market volatilityLow Drawdown Real Time Trading Tips Shared - metal.it
How might ACLX's 2025 Q1 EPS forecast affect strategies? - AInvest
What makes Arcellx Inc. stock price move sharplyWealth Building Review That Work - jammulinksnews.com
What markets is CHEF expanding into Is Arcellx Inc. stock a good long term investment optionFree Investment Community - jammulinksnews.com
How volatile is Arcellx Inc. stock compared to the marketAchieve exceptional returns with expert guidance - jammulinksnews.com
What are the technical indicators suggesting about Arcellx Inc.Unlock powerful trading signals and alerts - jammulinksnews.com
How does Arcellx Inc. compare to its industry peersExceptional earning trajectories - jammulinksnews.com
What are analysts’ price targets for Arcellx Inc. in the next 12 monthsInvest confidently with professional market insights - jammulinksnews.com
Is this a good reentry point in Arcellx Inc.Free Daily Growth Stock Pick Reports - Newser
Volume spikes in Arcellx Inc. stock – what they meanFree High Conviction Intraday Stock Signals - Newser
Can you recover from losses in Arcellx Inc.Low Risk Stock Trade Opportunity Analysis - Newser
Is Arcellx Inc. a growth stock or a value stockExceptional stock performance - jammulinksnews.com
Is it the right time to buy Arcellx Inc. stockLightning-fast capital gains - jammulinksnews.com
How does Arcellx Inc. generate profit in a changing economyInvest like a pro with expert recommendations - jammulinksnews.com
Why is Arcellx Inc. stock attracting strong analyst attentionDynamic profit expansion - jammulinksnews.com
What are Arcellx Inc. company’s key revenue driversAchieve triple-digit returns with smart investing - jammulinksnews.com
Arcellx Inc. Stock Performance After Earnings: Historical InsightsConsistent Growth Alert - Newser
Why Arcellx Inc. stock attracts strong analyst attentionFree Smart Money Group - Newser
Arcellx, Inc. (NASDAQ:ACLX) Holdings Reduced by New York State Common Retirement Fund - Defense World
What analysts say about Arcellx Inc. stockRapid wealth multiplication - PrintWeekIndia
What drives Arcellx Inc. stock priceSuperior portfolio returns - PrintWeekIndia
What analysts say about Arcellx Inc. stock outlookBreakthrough investment results - jammulinksnews.com
How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com
Victory Capital Management Inc. Sells 6,073 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Given Average Recommendation of “Buy” by Analysts - Defense World
Arcellx Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
Is Arcellx Inc. a good long term investmentFree Trading Strategy Suggestions - jammulinksnews.com
Bank of New York Mellon Corp Cuts Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Principal Financial Group Inc. Sells 184 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Xponance Inc. Acquires 190 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Inc Stock (ACLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):